DocuGuru
BMC (BioMed Central)

Genetic Vaccines and Therapy Template

Write in a clean editor, then format for Genetic Vaccines and Therapy in one click — DocuGuru applies the official BMC (BioMed Central) template with numbered references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.

Use this template

About the Genetic Vaccines and Therapy format

Genetic Vaccines and Therapy is a peer-reviewed journal published by BMC (BioMed Central), covering Virus-based gene therapy research, RNA Interference and Gene Delivery, Immunotherapy and Immune Responses.

PublisherBMC (BioMed Central)
Reference styleNumbered (Vancouver)
Numbered — [1], [2] in the text
1. Smith A, Jones B, Lee C. A representative article title. Genetic Vaccines and Therapy. 2023;12(3):45–58.

Formats any DOI in Genetic Vaccines and Therapy style. No sign-up.

Publishes research inVirus-based gene therapy research RNA Interference and Gene Delivery Immunotherapy and Immune Responses Cancer Research and Treatments HIV Research and Treatment
ISSN1479-0556
h-index33
i10-index79
Total citations3,225
Top institutions publishing hereUniversidade de São Paulo
Journal websitelink.springer.com
You getA submission-ready PDF and the editable LaTeX source — ready to submit.

Papers published in Genetic Vaccines and Therapy per year

3
2003
17
2004
8
2005
4
2006
13
2007
16
2008
14
2009
8
2010
15
2011
10
2012

Citation impact of Genetic Vaccines and Therapy by publication year

294
2003
796
2004
156
2005
206
2006
428
2007
458
2008
297
2009
213
2010
210
2011
162
2012

Citations each year’s papers have accumulated so far — the most recent years are still building up.

Most-cited papers in Genetic Vaccines and Therapy

The use of retroviral vectors for gene therapy-what are the risks? A review of retroviral pathogenesis and its relevance to retroviral vector-mediated gene delivery

Donald S. Anson · 13 Aug 2004

Retroviral vector-mediated gene transfer has been central to the development of gene therapy. Retroviruses have several distinct advantages over other vectors, especially when permanent gene transfer is the preferred outcome. The most important advantage that retroviral vectors offer is their ability to transform their single stranded RNA genome into a double stranded DNA molecule that…

152 citations Cite SaveGo to paper →
DNA vaccine constructs against enterovirus 71 elicit immune response in mice

Wong Siew Tung, Sazaly Abu Bakar, Zamberi Sekawi et al. · 19 Apr 2007

BACKGROUND: Enterovirus 71 (EV71) is a major causative viral agent responsible for large outbreaks of hand, foot and mouth disease (HFMD), a common rash illness in children and infants. There is no effective antiviral treatment for severe EV71 infections and no vaccine is available. The objectives of this study were to design and construct a…

112 citations Cite SaveGo to paper →
Skipping the co-expression problem: the new 2A "CHYSEL" technology

Pablo de Felipe · 13 Sep 2004

The rapid progress in the field of genomics is increasing our knowledge of multi-gene diseases. However, any realistic hope of gene therapy treatment for those diseases needs first to address the problem of co-ordinately co-expressing several transgenes. Currently, the use of internal ribosomal entry sites (IRESs) is the strategy chosen by many researchers to ensure…

109 citations Cite SaveGo to paper →

Genetic Vaccines and Therapy template — frequently asked questions

How do I write a paper in the Genetic Vaccines and Therapy format?
In DocuGuru you write your manuscript in a normal editor — no LaTeX setup required — and select the Genetic Vaccines and Therapy template. When you export, DocuGuru compiles the paper into the official BMC (BioMed Central) format and hands you a submission-ready PDF along with the editable LaTeX source.
What reference style does Genetic Vaccines and Therapy use?
Genetic Vaccines and Therapy uses Numbered (Vancouver) references, shown as numbered [1], [2] markers in the text. DocuGuru formats every in-text citation and the reference list in this exact style automatically. A reference appears like this: 1. Smith A, Jones B, Lee C. A representative article title. Genetic Vaccines and Therapy. 2023;12(3):45–58.
Do I need to know LaTeX to submit to Genetic Vaccines and Therapy?
No. DocuGuru generates the bmcart LaTeX class and compiles the PDF for you in the background, so you get a BMC (BioMed Central)-ready Genetic Vaccines and Therapy document without writing any LaTeX. If you do want it, the LaTeX source is included in the export.
Can I import an existing draft into the Genetic Vaccines and Therapy template?
Yes. Paste or upload your current manuscript — Word, LaTeX, Markdown, or plain text — and DocuGuru reflows it into the Genetic Vaccines and Therapy format with correct headings, figures, tables, and numbered citations.
Who publishes Genetic Vaccines and Therapy?
Genetic Vaccines and Therapy is a life sciences and medicine journal published by BMC (BioMed Central). DocuGuru's Genetic Vaccines and Therapy template matches BMC (BioMed Central)'s official submission format.
Can I export a submission-ready Genetic Vaccines and Therapy PDF?
Yes — DocuGuru produces a PDF built with the official Genetic Vaccines and Therapy template (the bmcart class) that is ready to submit to BMC (BioMed Central), together with the matching LaTeX source files.
How much does the Genetic Vaccines and Therapy template cost?
You can start writing in the Genetic Vaccines and Therapy template for free. Exporting the final submission-ready Genetic Vaccines and Therapy PDF and LaTeX source is part of DocuGuru's paid plans — see the app for current pricing.
Use the Genetic Vaccines and Therapy template